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Increasing incidence of childhood leukaemia: a controversy
re-examined
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We provide evidence of a gradual increase in the incidence of childhood leukaemia over the twentieth century from examination of
trends in both incidence and mortality in England and Wales. We conclude that much of the recorded increase is likely to be real.
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In Europe, childhood lymphoid leukaemia incidence (including
acute lymphoblastic leukaemia (ALL)) increased significantly by
an average of 1.4% per year during 1970– 1999 (Steliarova-Foucher
et al, 2004). In England and Wales, the increase in ALL has been
attributed to the ‘common’ precursor B-cell subtype (Feltbower
et al, 2001; Kroll et al, 2006). Debate has arisen over whether the
increase is artefactual (Leukaemia Research Fund, 2004; Adamson
et al, 2005) or real (Steliarova-Foucher et al, 2004, 2005).
Fewer than 5% of children diagnosed with leukaemia in England
before the early 1960s survived more than 5 years after diagnosis
(Thames Cancer Registry, 1994), and mortality trends before 1960
may thus be considered a reasonable proxy for incidence. We have
therefore examined all the available data on incidence and
mortality trends for childhood leukaemia in England and Wales
over most of the twentieth century.
Leukaemia is the commonest cancer in children (0–14 years),
representing a third of all malignancies (Parkin et al, 1998).
Incidence rates increase to a peak around age 3– 4 years and then
decline (Swerdlow et al, 2001). Some 400 children are diagnosed in
England and Wales each year, and about 100 die of it. Four out of
five cases of leukaemia in children are ALL, and the remaining
almost all acute myeloid leukaemia (AML).
MATERIALS AND METHODS
Data on childhood leukaemia incidence and mortality in England
and Wales up to the year 2000 were used to examine trends by age
(under 1 year, and 1 –4, 5–9, 10–14 years), sex and 5-year period.
Mortality data for 1911–2000 and incidence data for 1971–1990
were obtained from the Office for National Statistics (ONS) (Office
for National Statistics, 1998, 2003). Additional cancer registration
data for the period 1991–2000 were obtained separately from ONS.
Annual incidence and mortality rates for children aged 0–14 years
were adjusted to the world standard population (Parkin et al,
1992). Variance-weighted least-squares linear regression was used
to estimate the average quinquennial change in incidence and
mortality rates.
Mortality data held by ONS span the whole of the twentieth
century. Before 1959, however, the only data available are those
published in the Registrar General’s Annual Reviews. Compu-
terised information on individual deaths has only been available
since 1959. These data have been published on CD-ROM (Office
for National Statistics, 2003).
Death registrations derived from medical certificates of cause of
death are coded at ONS to the World Health Organisation’s (WHO)
International Classification of Diseases (ICD). The ICD underwent
10 revisions during the twentieth century, reflecting successive
advances in medical knowledge and disease classification. The first
version, in force during 1901–1910, did not include a separate
category for leukaemia, so it is impossible to estimate national
mortality rates for childhood leukaemia before 1911. The ICD codes
for leukaemia data used in the analyses are given in Table 1.
The ONS has coordinated cancer registration nationally in
England and Wales since 1971 through a network of population-
based regional cancer registries in England and a national cancer
registry in Wales (Office for National Statistics, 2004a).
RESULTS
Childhood leukaemia mortality rates increased four-fold from 8.4
per million person-years in 1911–1915 to reach 34.7 by the late
1950s (Figure 1). The decline in mortality over the second half of
the twentieth century to 10.3 per million person-years has been
similarly impressive.
Leukaemia mortality peaked earlier for children under 5 years of
age (1941 –1955) than for older children (1956–1970). The 5-yearly
decline in childhood leukaemia mortality was significant for each
age group over the period 1971–2000. Peak mortality varied widely
by age, from 23.4 per million for children aged 10– 14 years to 51.8
at ages 1– 4 years (Table 2). The increase and almost symmetric
decrease in mortality is particularly marked in children aged 1– 4
years, with a peak of 51.8 deaths per million person-years during
1951– 1955, declining by 80% to 10.6 by 1996–2000.
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Incidence rose by 20% between the early 1970s and the end of
the century (Figure 1), an increase of 4% every 5 years. Both
incidence and mortality were at least 15% higher in boys than girls
throughout the twentieth century. Incidence at ages 1 –4 years was
more than double that of any other age group (Table 3). The
average 5-yearly increase in incidence over the period 1971–2000
was significant in all age groups, but the overall increase was much
larger among children under 5 years (46% in infants, 24% in
children aged 1–4 years) than in older children (12–15%).
DISCUSSION
The divergence between rising incidence and falling mortality
is remarkable, but it reflects the great improvement in 5-year
survival, from less than 5% in the early 1960s (Thames Cancer
Registry, 1994) to almost 80% by the end of the 1990s (Coleman
et al, 1999; Shah, 2005). Since survival was so low before the early
1960s, it seems likely that mortality from 1911 up to the 1950s
provides a reasonable proxy for incidence trends. Taken together
with the directly observed incidence trends from the 1970s to the
late 1990s, these data strongly suggest a century-long increase in
childhood leukaemia, particularly in children under 5 years of age.
Similar trends for childhood leukaemia have been observed in
the United States, with an increase in mortality until the 1960s. The
subsequent decline in mortality, resulting from improvements in
treatment, has been seen world-wide (Fraumeni and Miller, 1967;
Coleman et al, 1993; Smith et al, 1999). Incidence has increased
significantly in Europe and in the United States since the 1970s,
which is essentially attributable to ALL (Coleman et al, 1993; Smith
et al, 1999; Xie et al, 2003; Steliarova-Foucher et al, 2004).
However, the incidence of ALL and AML has been stable in the
Nordic countries between 1982 and 2001 (Hjalgrim et al, 2003).
The childhood peak at 2 –4 years that began to develop in the
1920s in England and Wales developed later in other nations, for
example in the 1940s in US Caucasians and in the 1960s in Japan
and in US non-Caucasians, but it has not been seen in some
developing countries (Fraumeni and Miller, 1967; Greaves et al,
1985). Differences in leukaemia incidence, most apparent at ages
2–3 years, have been observed between Caucasian and African-
American children in the United States, and between children
in western and eastern Europe (Doll, 1989; Smith et al, 1999;
Steliarova-Foucher et al, 2004). The development of this age peak
is the main component of the overall increase in leukaemia
incidence in England and Wales and other countries over the
twentieth century.
The cause of childhood leukaemia remains unknown. It has
been suggested that a leukaemic exposure arose in developed
countries in the early part of the twentieth century possibly
associated with improved living standards (Doll, 1989). Although
improvements in case-finding and in the accuracy of death
certification in England and Wales are considered to have had
an impact on childhood leukaemia mortality, particularly during
the early part of the century, the continued increase in mortality
into, and beyond, the 1950s indicates a real increase in incidence
(Court Brown and Doll, 1961; Doll, 1989; Swerdlow et al, 2001).
More complete ascertainment by cancer registries has also been
proposed (Adamson et al, 2005), and while this may have had
some impact in the early 1970s, under-ascertainment of childhood
cancers has been estimated at less than 5% during 1971–1984
(Hawkins and Swerdlow, 1992). It also seems implausible that
any systematic underreporting of leukaemia would have been
restricted to children under 5 years, and particularly to those with
the precursor B-cell subtype of ALL.
It has been hypothesised that, in the first few decades of the
twentieth century, a fatal infection (e.g. pneumonia) attributable to
pre-leukaemic immunosuppression would have killed a proportion
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Figure 1 Trends in leukaemia incidence, survival and mortality in children (0–14 years), England and Wales, 1911–2000. Incidence and mortality rates
per million person-years for England and Wales (Office for National Statistics, 1998, 2003). Five-year relative survival rates (%) for children diagnosed in
South-East England 1960–1970 (Thames Cancer Registry, 1994), in England and Wales during 1971–1990 (Coleman et al, 1999) and in Great Britain
1991–2000 (Shah, 2005).
Table 1 International classification of disease codes for leukaemia
ICD revision Mortality
Period in use
for mortality Incidence
Period in use
for incidence
2 53A 1911–1920 —
3 65A 1921–1930 —
4 72A 1931–1939 —
72B 1935–1939 —
5 74A and 74B 1940–1949 —
6 204 1950–1957 —
7 204 1958–1967 —
8 204–207 1968–1978 204–207 1971–1978
9 204–208 1979–2000 204–208 1979–1994
10 — — C91–C95 1995–2000
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of children before the leukaemia became obvious. After the
introduction of antibiotics, the effect of fatal infections in
‘masking’ leukaemia would have declined, leading to the observed
increase in leukaemia incidence (Stewart and Kneale, 1969). A
state-wide study in Colorado during 1941– 1959, however,
concluded that the severity and often fatal outcome of childhood
leukaemia would usually have resulted in hospitalisation, and that
few cases would have remained undiagnosed there (Githens et al,
1965).
Even if fatal infections may have had some impact on ‘masking’
leukaemia during the first half of the century, their involvement
cannot explain the increase in incidence of childhood leukaemia
during 1971–2000. Infant mortality (in the first year of life) fell
from 18 in 1971 to 6 per thousand live births in 2000 (ONS, 2004b).
If all other causes of death up to age 5 years are ignored, this would
allow some 12 000 children per million live births (18 minus 6 per
1000) each year to reach age 5 years who would not previously
have done so. Leukaemia incidence in children aged 1–4 years
increased from 64.5 per million person-years during 1971– 1975 to
79.8 during 1996–2000, an increase of 15.3 cases per million. The
incidence of leukaemia in the 12 000 ‘extra’ children per million
per year who would previously have died in infancy would have to
have been 1275 per million person-years, some 20 times higher
than in the rest of the population, in order for the overall decline in
infant mortality in the period 1971–2000 to account for the overall
increase in leukaemia incidence.
In 1940, the WHO rule for selecting the underlying cause when
more than one cause is mentioned on the death certificate
changed, with the introduction of ICD-5: this resulted in a 3%
reduction in leukaemia mortality at all ages (Swerdlow et al, 2001).
Similarly, aleukaemia, previously defined as lymphadenoma or
agranulocytosis, was included with leukaemia from 1950 (ICD-6).
These shifts would have caused small changes in the number of
childhood deaths coded to leukaemia, but cannot explain the
increase over a period of 40 years.
The above explanations seem unlikely to explain fully the long-
term changes in mortality and incidence, particularly since the
disparities in trends between girls and boys have been broadly
consistent over the century. We are forced to conclude that the
increase in incidence is largely real.
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Table 2 Childhood leukaemia mortality rate per million person-years by sex and age, England and Wales, 1911–2000
Period of death
Average
quinquennial
change
(1971 – 2000)
1911 –
1915
1916 –
1920
1921 –
1925
1926 –
1930
1931 –
1935
1936 –
1940
1941 –
1945
1946 –
1950
1951 –
1955
1956 –
1960
1961 –
1965
1966 –
1970
1971 –
1975
1976 –
1980
1981 –
1985
1986 –
1990
1991 –
1995
1996 –
2000
Time
trenda
95%
confidence
interval
All 8.4 8.0 10.2 15.2 18.4 22.3 25.5 30.4 34.1 34.7 32.9 29.7 26.4 22.0 17.1 14.0 10.9 10.3 3.8 3.8 3.8
Sex
Male 10.3 9.8 12.5 18.0 20.4 26.0 30.4 33.6 37.0 38.3 36.1 32.4 29.3 26.8 19.6 15.4 13.5 11.6 3.9 3.9 3.9
Female 6.4 6.2 8.0 12.3 16.3 19.2 20.5 27.2 31.9 30.9 29.4 27.0 23.3 17.0 14.6 12.6 8.1 8.9 3.2 3.2 3.2
Age (years)
o1 9.9 10.8 11.6 17.4 19.7 28.4 29.4 25.1 29.0 23.2 24.8 19.4 18.8 13.8 12.7 8.9 9.5 6.4 2.2 3.0 1.3
1 – 4 11.5 10.2 13.4 21.9 25.5 33.6 36.0 46.8 51.8 48.5 43.8 37.9 30.6 21.7 16.4 14.8 9.4 10.6 3.7 4.2 3.1
5 – 9 7.5 7.0 9.5 12.6 16.2 18.4 22.1 26.3 29.7 35.6 34.7 30.2 30.9 27.2 18.7 13.6 12.2 10.0 4.1 4.6 3.7
10 – 14 5.5 6.1 7.3 10.3 12.8 13.0 17.2 19.1 21.3 22.0 21.3 23.4 18.9 18.9 17.4 15.0 11.2 11.3 1.8 2.3 1.4
aAverage quinquennial change in the mortality rate per million person-years between 1971–1975 and 1996–2000. Mortality rates are age-standardised to the world standard
population.
Table 3 Childhood leukaemia incidence rate per million person-years by sex and age, England and Wales, 1971–2000
Period of diagnosis Average quinquennial change (1971–2000)
1971–1975 1976–1980 1981–1985 1986–1990 1991–1995 1996–2000 Time trenda 95% confidence intervals
All 38.3 39.2 41.3 42.5 43.7 46.1 1.5 1.5 1.5
Sex
Male 43.7 43.4 44.9 45.8 49.4 49.8 1.3 1.3 1.3
Female 32.6 34.7 37.6 39.0 37.8 42.2 1.7 1.7 1.7
Age (years)
o1 25.5 25.3 29.2 33.2 32.9 37.2 2.4 1.0 3.8
1–4 64.5 66.6 69.0 72.6 72.9 79.8 2.8 1.7 3.8
5–9 32.0 31.6 33.7 32.6 34.4 35.8 0.8 0.1 1.4
10–14 20.7 22.1 23.5 23.7 25.7 23.9 0.8 0.3 1.3
aAverage quinquennial change in the incidence rate per million person-years between 1971–1975 and 1996–2000. Incidence rates are age-standardised to the world standard
population.
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